Co-Diagnostics, Inc.
CODX
$0.375
$0.01985.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.76% | -27.60% | 18.39% | 36.55% | -145.34% |
| Total Depreciation and Amortization | 1.68% | 3.81% | 2.33% | 5.66% | 5.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.83% | -49.80% | 74.10% | -88.05% | 1,691.48% |
| Change in Net Operating Assets | 39.87% | 305.84% | 159.11% | -144.25% | 158.95% |
| Cash from Operations | -13.85% | -38.92% | 38.70% | -77.67% | 17.11% |
| Capital Expenditure | 58.14% | -76.88% | 75.49% | 13.41% | -96.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -92.19% | 210.29% | -123.06% | 69.40% | 291.13% |
| Cash from Investing | -93.62% | 203.27% | -124.21% | 73.40% | 310.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 3.97% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | 3.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -156.80% | 66.87% | -212.93% | 74.95% | 230.25% |